NCT06016257 Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study
| NCT ID | NCT06016257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Shoulder Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-02-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be performed to determine if Band Connect's VirtuaCare™ platform increases patient compliance and provides an effective alternative to current physical therapy treatment while reducing the frequency of visits compared with standard orthopedic physical therapy treatment performed in the outpatient clinic. Participants are being asked to take part in this research study if 18 years and older and have been prescribed physical therapy rehabilitation for an acute or chronic shoulder condition and as part of the participant's physical therapy will receive a shoulder exercise home program.
Eligibility Criteria
Inclusion Criteria: Physical therapy home program subjects * Subject 18 years or older * Outpatient physical therapy prescribed by doctor for shoulder rehabilitation. * No previous neurological condition * Understand English (exercises are only in English) Physical therapists * The therapists will be the ones who provide physical therapy treatment to the acute and chronic shoulder population. Patients who had usual and customary treatment for acute and chronic shoulder conditions • Any patient referred based on inclusion criteria noted above that are referred for outpatient physical therapy and had a previous acute or chronic shoulder condition, were 18 years and older and had no previously documented neurological condition. Exclusion Criteria: Physical therapy home program subjects * Prior surgery within the last 5 years or less than 6 months between surgery * Neurologic comorbidities that have functional deficits * Uncontrolled diabetes * Diagnosis with active cancer in the last two years * Unable to understand English Physical therapists • Any therapist who does not provide physical therapy treatment for acute and chronic shoulder conditions. Patients who had usual and customary treatment for acute and chronic shoulder conditions • Any patient who had prior surgery within the last 5 years or less than 6 months between surgery, had neurological comorbidities that had documented functional deficits, documented uncontrollable diabetes, documented diagnosis of active cancer within the last two years.
Contact & Investigator
Pamela S Roberts, PhD
PRINCIPAL INVESTIGATOR
Cedars-Sinai Medical Center
Frequently Asked Questions
Who can join the NCT06016257 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Shoulder Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06016257 currently recruiting?
Yes, NCT06016257 is actively recruiting participants. Contact the research team at pamela.roberts@cshs.org for enrollment information.
Where is the NCT06016257 trial being conducted?
This trial is being conducted at Los Angeles, United States, Los Angeles, United States.
Who is sponsoring the NCT06016257 clinical trial?
NCT06016257 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Pamela S Roberts, PhD at Cedars-Sinai Medical Center. The trial plans to enroll 20 participants.